NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Acacia Research Corporation (NASDAQ: ACTG) announced today that a subsidiary has acquired 13 US and foreign patents and applications on fluorescence microscopy. “Acacia continues to increase the number of leading patent portfolios in the medical device and life sciences space,” commented Matt Vella, CEO. “Fluorescence microscopy is of key relevance to the life sciences because it enables three-dimensional imaging of cellular constituents with unrivaled specificity.”
Help employers find you! Check out all the jobs and post your resume.